Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside

Mayo Clinic Proceedings

Volumn 77, Issue 8, 2002, Pages 760-762

  Hogan, William J ^a   Letendre, Louis ^a   Litzow, Mark R ^a   Tefferi, Ayalew ^a   Hoagland, H Clark ^a   Pruthi, Rajiv K ^a   Kaufmann, Scott H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYTARABINE; IDARUBICIN; METRONIDAZOLE; VANCOMYCIN;

ABDOMINAL PAIN; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; CAUSE OF DEATH; COLITIS; CONFERENCE PAPER; DIARRHEA; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL TOXICITY; HEMATOCHEZIA; HUMAN; INFLAMMATION; INTESTINE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEUTROPENIA; PERITONITIS; SEPSIS;

EID: 0036326992     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.8.760     Document Type: Conference Paper

References (10)

1. Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: A CALGB study
2. Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia
3. A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: A Southeastern Cancer Study Group Study
4. A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia: A multicentric study from the Italian Co-operative Group GIMEMA
5. Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
6. A phase III study of daunorubicin vs idarubicin vs mitoxantrone for older adult patients (>55 yrs) with acute myelogenous leukemia (AML): A study of the Eastern Cooperative Oncology Group (E3993)
7. A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia
8. Neutropenic enterocolitis: Spectrum of the disease and comparison of definite and possible cases
9. Neutropenic enterocolitis
10. Neutropenic enterocolitis following treatment with cytosine arabinoside-containing regimens for hematological malignancies: A potentiating role for amsacrine